KDP Q4 Earnings & Revenues Beat Estimates, Sales Increase 10.5%

Core Insights - Keurig Dr Pepper Inc. (KDP) reported strong fourth-quarter 2025 results, with both revenue and earnings exceeding expectations and showing year-over-year improvement [1][2] Financial Performance - KDP's net sales reached $4.5 billion, a 10.5% increase year over year, surpassing the Zacks Consensus Estimate of $4.36 billion. On a constant currency basis, net sales increased by 9.9%, driven by a 3.9% gain in volume/mix and a 6% benefit from favorable net pricing [4] - Adjusted earnings per share (EPS) were 60 cents, reflecting a 1.7% year-over-year growth and exceeding consensus estimates by a penny. This improvement was attributed to higher adjusted operating income, despite a slightly higher tax rate and increased interest expense [5] - Adjusted gross profit rose 7.7% year over year to $2.47 billion, while the adjusted gross margin decreased by 140 basis points to 54.9% [5] Segment Performance - In the U.S. Refreshment Beverages segment, net sales increased 11.5% year over year to $2.7 billion, supported by a 7% rise in volume/mix and a 4.5% benefit from favorable net pricing. The acquisition of GHOST contributed 6.2 percentage points to this growth [7] - Adjusted operating income for the U.S. Refreshment Beverages segment rose 8.7% year over year to $841 million, representing 30.9% of net sales [8] - The U.S. Coffee segment saw net sales increase by 3.9% year over year to $1.2 billion, primarily driven by K-Cup sales, despite a 4.1% decline in volume/mix [9] - Adjusted operating income in the U.S. Coffee segment fell 8.8% year over year to $364 million, or 31% of net sales, due to inflationary pressures and decreased volume/mix [10] - The International segment's net sales increased 21% year over year to $604 million, with a 9.2% benefit from favorable net pricing and a 6.8% increase in volume/mix [12] - Adjusted operating income for the International segment increased 20% to $163 million, representing 27% of net sales [13] Financial Health - As of December 31, 2025, KDP had cash and cash equivalents of $1,026 million, long-term obligations of $13.03 billion, and total stockholders' equity of $25.5 billion. Net cash provided by operating activities totaled $1.99 billion, with free cash flow amounting to $1.52 billion [14] 2026 Outlook - For 2026, KDP expects constant currency net sales in the range of $25.9 billion to $26.4 billion, with low-double-digit EPS growth anticipated. This outlook assumes 4-6% growth in both net sales and adjusted earnings, along with contributions from the JDE Peet's acquisition [15][16]